Journey Medical Corporation (DERM) Q4 2024 Annual Earnings
DERM·Reported March 26, 2025·After market close
Journey Medical Corporation reported Q4 2024 revenue of $13.6M, beat analyst consensus of $12.1M by $1.6M. Diluted EPS came in at $0.08, beat the $-0.22 consensus by $0.30.
Revenue
$13.6Mbeat by $1.6M
Consensus: $12.1MDiluted EPS
$0.08beat by $0.30
Consensus: $-0.22
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Journey Medical Corporation's Q4 2024 earnings report.
Journey Medical Corporation (DERM) reported Q4 2024 earnings on March 26, 2025 after market close.
Journey Medical Corporation reported revenue of $13.6M and diluted EPS of $0.08 for Q4 2024.
Revenue beat the consensus estimate of $12.1M by $1.6M. EPS beat the consensus estimate of $-0.22 by $0.30.
You can read the 10-K periodic report (0001410578-25-000490) directly on SEC EDGAR. The filing index links above go to sec.gov.